Superagonistic Fluorinated Vitamin D3 Analogs Stabilize Helix 12 of the Vitamin D Receptor

被引:38
作者
Eelen, Guy [1 ]
Valle, Noelia [2 ]
Sato, Yoshiteru [3 ]
Rochel, Natacha [3 ]
Verlinden, Lieve [1 ]
De Clercq, Pierre [4 ]
Moras, Dino [3 ]
Bouillon, Roger [1 ]
Munoz, Alberto [2 ]
Verstuyf, Annemieke [1 ]
机构
[1] Katholieke Univ Leuven, LEGENDO, B-3000 Louvain, Belgium
[2] Univ Autonoma Madrid, CSIC, Inst Invest Biomed Alberto Sols, E-28029 Madrid, Spain
[3] Dept Biol & Genom Struct, IGBMC, F-67400 Illkirch Graffenstaden, France
[4] Univ Ghent, Vakgroep Organ Chem, B-9000 Ghent, Belgium
来源
CHEMISTRY & BIOLOGY | 2008年 / 15卷 / 10期
关键词
D O I
10.1016/j.chembiol.2008.08.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Side chain fluorination is often used to make analogs of 1,25-dihydroxyvitamin D-3 [1,25(OH)(2)D-3] resistant to degradation by 24-hydroxylase. The fluorinated nonsteroidal analogs CD578, WU515, and WY1113 have an increased prodifferentiating action on SW480-ADH colon cancer cells, which correlated with stronger induction of vitamin D receptor (VDR)-coactivator interactions and stronger repression of beta-catenin/TCF activity. Cocrystallization of analog CD578 with the zebrafish (z)VDR and an SRC-1 coactivator peptide showed that the fluorine atoms of CD578 make additional contacts with Va1444 and Phe448 of activation helix 12 (H12) of the zVDR and with Leu440 of the H11-H12 loop. Consequently, the SRC-1 peptide makes more contacts with the VDR-CD578 complex than with the VDR-1,25(OH)(2)D-3 Complex. These data show that fluorination not only affects degradation of an analog but can also have direct effects on H12 stabilization.
引用
收藏
页码:1029 / 1034
页数:6
相关论文
共 50 条
[31]   Polymorphism of the vitamin D3 receptor in patients with psoriasis [J].
Okita, H ;
Ohtsuka, T ;
Yamakage, A ;
Yamazaki, S .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2002, 294 (04) :159-162
[32]   Development of Vitamin D Analogs Modulating the Pocket Structure of Vitamin D Receptor [J].
Yamamoto, Keiko ;
Anami, Yasuaki ;
Itoh, Toshimasa .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2014, 14 (21) :2378-2387
[33]   Mediating transcriptional activation by the vitamin D3 receptor [J].
Freedman, LP ;
Rachez, C ;
Burakov, D ;
Gamble, MJ ;
Yang, W ;
Chang, CP .
BONE, 2001, 28 (05) :S69-S69
[34]   Effects of 1,25-Dihydroxyvitamin D3 and Vitamin D3 on the Expression of the Vitamin D Receptor in Human Skeletal Muscle Cells [J].
Pojednic, Rachele M. ;
Ceglia, Lisa ;
Olsson, Karl ;
Gustafsson, Thomas ;
Lichtenstein, Alice H. ;
Dawson-Hughes, Bess ;
Fielding, Roger A. .
CALCIFIED TISSUE INTERNATIONAL, 2015, 96 (03) :256-263
[35]   Calcium and vitamin D3 [J].
不详 .
NUTRITION & FOOD SCIENCE, 2007, 37 (06) :65-67
[36]   Effects of 1,25-Dihydroxyvitamin D3 and Vitamin D3 on the Expression of the Vitamin D Receptor in Human Skeletal Muscle Cells [J].
Rachele M. Pojednic ;
Lisa Ceglia ;
Karl Olsson ;
Thomas Gustafsson ;
Alice H. Lichtenstein ;
Bess Dawson-Hughes ;
Roger A. Fielding .
Calcified Tissue International, 2015, 96 :256-263
[37]   1ALPHA,25-DIHYDROXYVITAMIN-D3 D3 RECEPTOR - COMPETITIVE BINDING OF VITAMIN-D ANALOGS [J].
BRUMBAUGH, PF ;
HAUSSLER, MR .
LIFE SCIENCES, 1973, 13 (12) :1737-1746
[38]   Is Vitamin D2 Really Bioequivalent to Vitamin D3? [J].
Bouillon, Roger ;
Verlinden, Lieve ;
Verstuyf, Annemieke .
ENDOCRINOLOGY, 2016, 157 (09) :3384-3387
[39]   COMPARISON OF VITAMIN D2 AND VITAMIN D3 IN HYPOPARATHYROIDISM [J].
FOURMAN, P ;
LEESON, PM .
ACTA ENDOCRINOLOGICA, 1965, S 50 :156-&
[40]   Is vitamin D2 better than vitamin D3? [J].
Atik, O. Sahap .
EKLEM HASTALIKLARI VE CERRAHISI-JOINT DISEASES AND RELATED SURGERY, 2012, 23 (02) :61-61